Nina Moreno, Nelson Labs, explains how rapid sterility testing is reshaping pharmaceutical quality control—cutting release ...
Saharsh Davuluri, Neuland Labs, urges API and peptide automation by 2026 to match modern biologics standards.
PharmTech recently spoke with Saharsh Davuluri, Vice Chairman and Managing Director, Neuland Labs, to get his perspective on trends that shaped pharmaceutical development and manufacturing in 2025 and ...
Rare diseases, defined by FDA as “a disease or condition that affects less than 200,000 people in the United States” (1), may ...
The company’s new AI agent automates labor-intensive processes involved in trial document management.
Paolo Ferrigno Product Manager prefilled syringes and cartridges Datwyler Healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback